Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Current Opinion in Drug Discovery & Development
|
July 3, 2010
Recent progress in liver X receptor-selective modulators
Hassen Ratni, Matthew B Wright
Expert Opinion on Therapeutic Patents
|
March 23, 2011
Tachykinin neurokinin 3 receptor antagonists: a patent review (2005 - 2010)
Pari Malherbe, Theresa M Ballard, Hassen Ratni
Bioorganic & Medicinal Chemistry Letters
|
August 1, 2006
Synthesis and evaluation of anilinohexafluoroisopropanols as activators/modulators of LXRalpha and beta
Narendra Panday, Jörg Benz, Denise Blum-Kaelin, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 24, 2009
Discovery of tetrahydro-cyclopenta[b]indole as selective LXRs modulator
Hassen Ratni, Denise Blum-Kaelin, Henrietta Dehmlow, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 21, 2010
Rational design of novel pyrrolidine derivatives as orally active neurokinin-3 receptor antagonists
Hassen Ratni, Theresa M Ballard, Caterina Bissantz, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Current Opinion in Drug Discovery & Development
|
July 3, 2010
Recent progress in liver X receptor-selective modulators
Hassen Ratni, Matthew B Wright
Expert Opinion on Therapeutic Patents
|
March 23, 2011
Tachykinin neurokinin 3 receptor antagonists: a patent review (2005 - 2010)
Pari Malherbe, Theresa M Ballard, Hassen Ratni
Bioorganic & Medicinal Chemistry Letters
|
August 1, 2006
Synthesis and evaluation of anilinohexafluoroisopropanols as activators/modulators of LXRalpha and beta
Narendra Panday, Jörg Benz, Denise Blum-Kaelin, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 24, 2009
Discovery of tetrahydro-cyclopenta[b]indole as selective LXRs modulator
Hassen Ratni, Denise Blum-Kaelin, Henrietta Dehmlow, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 21, 2010
Rational design of novel pyrrolidine derivatives as orally active neurokinin-3 receptor antagonists
Hassen Ratni, Theresa M Ballard, Caterina Bissantz, et al.
Page
of 1